Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K Soeken
Health-Related Quality of Life in Patients Receiving Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia
Cancer Control
Medicine
Oncology
Hematology
Incidence and Outcomes of Primary Engraftment Failure in Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Reduced-Intensity Conditioning Regimen for Patients With Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Achieving Stringent CR Is Essential Before Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in AML
Bone Marrow Transplantation
Transplantation
Hematology
Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient Versus Outpatient Setting
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin
Neoplasma
Cancer Research
The Current Status of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation Using Fludarabine–melphalan Conditioning for Treatment of Mature T-Cell Lymphomas
Bone Marrow Transplantation
Transplantation
Hematology
Improvement in Health-Related Quality of Life for Sickle Cell Disease Patients Treated With Chemotherapy-Free Allogeneic Hematopoietic Stem-Cell Transplantation: A Pilot Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
